Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Performance and Safety Assessment of T4020 in Managing Corneal Epithelial Defect Following Epi-off Accelerated Crosslinking

NCT02979054 is registered in ClinicalTrials.gov with Laboratoires Thea as lead sponsor.

NCT NCT02979054
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02979054 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Performance and Safety Assessment of T4020 in Managing Corneal Epithelial Defect Following Epi-off Accelerated Crosslinking
Lead sponsor
Laboratoires Thea
Phase
Not applicable
Overall status
Completed
Start date
December 31, 2016
Completion date
March 31, 2018
Enrollment
157 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

keratoconus